However, there was no significant difference in TP53, TNF, TLR4, TGFB1, PTGS2, PTEN, PPARG, MTOR, MMP9, INS, IL6, IL1B, IL10, IFNG, ESR1, CASP3, ALB, AKT1, GSK3A, ERBB2, IL1A, ICAM1, CAV1, and APP levels between control and AD groups in the hippocampus (data not shown). This evidence concerns the gene ICAM1 and Alzheimer disease.